| Year |
Citation |
Score |
| 2023 |
Guang S, O'Brien B, Fine AS, Ying M, Fatemi A, Nemeth C. Mutations in DARS2 result in global dysregulation of mRNA metabolism and splicing. Research Square. PMID 36909591 DOI: 10.21203/rs.3.rs-2603446/v1 |
0.384 |
|
| 2022 |
Li Q, Feng Y, Xue Y, Zhan X, Fu Y, Gui G, Zhou W, Richard JP, Taga A, Li P, Mao X, Maragakis NJ, Ying M. Edaravone activates the GDNF/RET neurotrophic signaling pathway and protects mRNA-induced motor neurons from iPS cells. Molecular Neurodegeneration. 17: 8. PMID 35012575 DOI: 10.1186/s13024-021-00510-y |
0.529 |
|
| 2021 |
Zhan D, Ma D, Wei S, Lal B, Fu Y, Eberhart C, Laterra J, Ying M, Li Y, Meeker A, Lopez-Bertoni H, Xia S. Monoallelic IDH1 R132H mutation mediates glioma cell response to anti-cancer therapies via induction of senescence. Molecular Cancer Research : McR. PMID 34348994 DOI: 10.1158/1541-7786.MCR-21-0284 |
0.318 |
|
| 2021 |
Xue Y, Fu Y, Zhao F, Gui G, Li Y, Rivero-Hinojosa S, Liu G, Li Y, Xia S, Eberhart CG, Ying M. Frondoside A Inhibits a MYC-driven Medulloblastoma Model Derived from Human Induced Pluripotent Stem Cells. Molecular Cancer Therapeutics. PMID 33722850 DOI: 10.1158/1535-7163.MCT-20-0603 |
0.431 |
|
| 2021 |
Laterra J, Ma T, Hu C, Lal B, Zhou W, Ma Y, Ying M, Prinos P, Quiñones-Hinojosa A, Lim M, Li Y. Reprogramming transcription factors Oct4 and Sox2 induces a BRD-dependent immunosuppressive transcriptome in GBM-propagating cells. Cancer Research. PMID 33574085 DOI: 10.1158/0008-5472.CAN-20-2489 |
0.348 |
|
| 2019 |
Xia S, Ma D, Liu S, Lal B, Wei S, Wang S, Zhan D, Zhang H, Lee RS, Gao P, Lopez-Bertoni H, Ying M, Li JJ, Laterra J, Wilson MA. Extracellular matrix protein tenascin C increases phagocytosis mediated by CD47 loss of function in glioblastoma. Cancer Research. PMID 30898840 DOI: 10.1158/0008-5472.Can-18-3125 |
0.35 |
|
| 2019 |
Gao M, Fu Y, John L, Ying M. Abstract 2608: EGF signaling activates a TAZ-driven oncogenic program in glioblastoma Cancer Research. 79: 2608-2608. DOI: 10.1158/1538-7445.Am2019-2608 |
0.361 |
|
| 2018 |
Xue Y, Zhan X, Sun S, Karuppagounder SS, Xia S, Dawson VL, Dawson TM, Laterra J, Zhang J, Ying M. Synthetic mRNAs Drive Highly Efficient iPS Cell Differentiation to Dopaminergic Neurons. Stem Cells Translational Medicine. PMID 30387318 DOI: 10.1002/Sctm.18-0036 |
0.592 |
|
| 2018 |
Tung B, Ma D, Wang S, Oyinlade O, Laterra J, Ying M, Lv SQ, Wei S, Xia S. Krüppel-like factor 9 and histone deacetylase inhibitors synergistically induce cell death in glioblastoma stem-like cells. Bmc Cancer. 18: 1025. PMID 30348136 DOI: 10.1186/S12885-018-4874-8 |
0.405 |
|
| 2018 |
Wang S, Shi X, Wei S, Ma D, Ajala O, Lv SQ, Ying M, Zhang YA, Claypool SM, Watkins P, Xia S. Krüppel-like factor 4 (KLF4) induces mitochondrial fusion and increases spare respiratory capacity of human glioblastoma cells. The Journal of Biological Chemistry. PMID 29507094 DOI: 10.1074/Jbc.Ra117.001323 |
0.365 |
|
| 2017 |
Zou L, Xue Y, Jones M, Heinbockel T, Ying M, Zhan X. The Effects of Quinine on Neurophysiological Properties of Dopaminergic Neurons. Neurotoxicity Research. PMID 29285614 DOI: 10.1007/S12640-017-9855-1 |
0.564 |
|
| 2017 |
Li Q, Han X, Lan X, Gao Y, Wan J, Durham F, Cheng T, Yang J, Wang Z, Jiang C, Ying M, Koehler RC, Stockwell BR, Wang J. Inhibition of neuronal ferroptosis protects hemorrhagic brain. Jci Insight. 2: e90777. PMID 28405617 DOI: 10.1172/Jci.Insight.90777 |
0.338 |
|
| 2016 |
Tilghman J, Schiapparelli P, Lal B, Ying M, Quinones-Hinojosa A, Xia S, Laterra J. Regulation of Glioblastoma Tumor-Propagating Cells by the Integrin Partner Tetraspanin CD151. Neoplasia (New York, N.Y.). 18: 185-98. PMID 26992919 DOI: 10.1016/J.Neo.2016.02.003 |
0.433 |
|
| 2015 |
Sun H, Ying M. Abstract 4444: Small molecule drug Verteporfin inhibits TAZ/YAP-driven signaling and tumorigenicity of breast cancer cells Cancer Research. 75: 4444-4444. DOI: 10.1158/1538-7445.Am2015-4444 |
0.413 |
|
| 2015 |
Sagal J, Eberhart CG, Ying M. Abstract 2892: A MYC-driven medulloblastoma model derived from human induced pluripotent stem cells Cancer Research. 75: 2892-2892. DOI: 10.1158/1538-7445.Am2015-2892 |
0.517 |
|
| 2014 |
Ying M, Tilghman J, Wei Y, Guerrero-Cazares H, Quinones-Hinojosa A, Ji H, Laterra J. Kruppel-like factor-9 (KLF9) inhibits glioblastoma stemness through global transcription repression and integrin α6 inhibition. The Journal of Biological Chemistry. 289: 32742-56. PMID 25288800 DOI: 10.1074/Jbc.M114.588988 |
0.482 |
|
| 2014 |
Sagal J, Zhan X, Xu J, Tilghman J, Karuppagounder SS, Chen L, Dawson VL, Dawson TM, Laterra J, Ying M. Proneural transcription factor Atoh1 drives highly efficient differentiation of human pluripotent stem cells into dopaminergic neurons. Stem Cells Translational Medicine. 3: 888-98. PMID 24904172 DOI: 10.5966/Sctm.2013-0213 |
0.599 |
|
| 2014 |
Tilghman J, Wu H, Sang Y, Shi X, Guerrero-Cazares H, Quinones-Hinojosa A, Eberhart CG, Laterra J, Ying M. HMMR maintains the stemness and tumorigenicity of glioblastoma stem-like cells. Cancer Research. 74: 3168-79. PMID 24710409 DOI: 10.1158/0008-5472.Can-13-2103 |
0.454 |
|
| 2014 |
Tilghman J, Laterra J, Ying M. Abstract 3014: Hyaluronan-mediated motility receptor maintains stemness and tumorigenic potential of glioblastoma stem cells Cancer Research. 74: 3014-3014. DOI: 10.1158/1538-7445.Am2014-3014 |
0.472 |
|
| 2012 |
Ying M, Tilghman J, Laterra J. Abstract 3476: Hyaluronan-mediated motility receptor as a novel target for inhibiting glioblastoma stem cells Cancer Research. 72: 3476-3476. DOI: 10.1158/1538-7445.Am2012-3476 |
0.46 |
|
| 2011 |
Li Y, Li A, Glas M, Lal B, Ying M, Sang Y, Xia S, Trageser D, Guerrero-Cázares H, Eberhart CG, Quiñones-Hinojosa A, Scheffler B, Laterra J. c-Met signaling induces a reprogramming network and supports the glioblastoma stem-like phenotype. Proceedings of the National Academy of Sciences of the United States of America. 108: 9951-6. PMID 21628563 DOI: 10.1073/Pnas.1016912108 |
0.467 |
|
| 2011 |
Ying M, Wang S, Sang Y, Sun P, Lal B, Goodwin CR, Guerrero-Cazares H, Quinones-Hinojosa A, Laterra J, Xia S. Regulation of glioblastoma stem cells by retinoic acid: role for Notch pathway inhibition. Oncogene. 30: 3454-67. PMID 21383690 DOI: 10.1038/Onc.2011.58 |
0.454 |
|
| 2011 |
Ying M, Sang Y, Li Y, Guerrero-Cazares H, Quinones-Hinojosa A, Vescovi AL, Eberhart CG, Xia S, Laterra J. Krüppel-like family of transcription factor 9, a differentiation-associated transcription factor, suppresses Notch1 signaling and inhibits glioblastoma-initiating stem cells. Stem Cells (Dayton, Ohio). 29: 20-31. PMID 21280156 DOI: 10.1002/Stem.561 |
0.507 |
|
| 2011 |
Li Y, Li A, Ying M, John L. Abstract 3310: Regulation of reprogramming factors by c-Met signaling in glioblastoma stem cells Cancer Research. 71: 3310-3310. DOI: 10.1158/1538-7445.Am2011-3310 |
0.466 |
|
| 2011 |
Ying M, Sang Y, Li Y, Guerrero-Cazares H, Quinones-Hinojosa A, Vescovi AL, Eberhart CG, Xia S, Laterra J. Abstract 3296: KLF9, a differentiation-associated transcription factor, suppresses Notch1 signaling and inhibits glioblastoma-initiating stem cells Cancer Research. 71: 3296-3296. DOI: 10.1158/1538-7445.Am2011-3296 |
0.522 |
|
| 2010 |
Ying M, Xia S, Laterra J. Abstract 5159: Kruppel-like factor 9 modulates the growth and differentiation of glioblastoma-derived neoplastic stem cells Cancer Research. 70: 5159-5159. DOI: 10.1158/1538-7445.Am10-5159 |
0.481 |
|
| 2010 |
Ying M, Sang Y, Lal B, Sun P, Laterra J, Xia S. Abstract 5158: Differentiation of glioblastoma stem-like cells induced by retinoic acid Cancer Research. 70: 5158-5158. DOI: 10.1158/1538-7445.Am10-5158 |
0.341 |
|
| 2009 |
Daher JP, Ying M, Banerjee R, McDonald RS, Hahn MD, Yang L, Flint Beal M, Thomas B, Dawson VL, Dawson TM, Moore DJ. Conditional transgenic mice expressing C-terminally truncated human alpha-synuclein (alphaSyn119) exhibit reduced striatal dopamine without loss of nigrostriatal pathway dopaminergic neurons. Molecular Neurodegeneration. 4: 34. PMID 19630976 DOI: 10.1186/1750-1326-4-34 |
0.371 |
|
| Show low-probability matches. |